-
October 4: The Week in Cancer News
Study finds people who receive brain radiation often recover cognitive abilities over time, and report details breast cancer trends.
by Thomas Celona
-
September 27: The Week in Cancer News
Adding MRI to prostate screening can help limit overdiagnosis, and breast cancer patients who smoke have a higher risk of radiotherapy-related lung cancer.
by Eric Fitzsimmons
-
September 20: The Week in Cancer News
The AACR spotlights cancer advances and challenges in new report, and the FDA approves second CDK 4/6 inhibitor to reduce risk of recurrence in early-stage breast cancer.
by Marci A. Landsmann
-
September 13: The Week in Cancer News
Mammogram findings will now include information about breast density, and youth vaping is on the decline.
by Kevin McLaughlin
-
September 6: The Week in Cancer News
Asian American and Pacific Islander women experience rising breast cancer incidence, and a study finds most people diagnosed with cancer will experience cognitive symptoms.
by Thomas Celona
-
August 30: The Week in Cancer News
Access to high-quality hospitals may be affected by insurance type, and the proliferation of digital tools could increase burdens on patients.
by Eric Fitzsimmons
-
August 23: The Week in Cancer News
Early immunotherapy may make more liver cancer patients eligible for surgery, and the FDA approves a new use for a lung cancer treatment.
by Kevin McLaughlin
-
August 16: The Week in Cancer News
Even small amounts of alcohol can increase cancer mortality risk, and research explores the role of weight-loss drugs in preventing cancer.
by Marci A. Landsmann
-
August 9: The Week in Cancer News
More endometrial cancer patients can now receive an immunotherapy, and taking aspirin regularly may help some people reduce their risk for colorectal cancer.
by Thomas Celona
-
August 2: The Week in Cancer News
Blood test approval widens access to colorectal cancer screening option, and language barriers interrupt cancer care before it starts.
by Eric Fitzsimmons
Cancer Talk
Delaying Treatment Resistance
Adding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
Cancer Today Editors’ Picks: 2024Our favorite Cancer Today stories from 2024, as picked by the editors.
Rethinking the Role of RadiationChest radiation may not be necessary for people with intermediate-risk breast cancer.
by Thomas Celona